Ornithine Transcarbamylase (OTC) Deficiency
3 clinical trials · Condition
◉ Watch Ornithine Transcarbamylase (OTC) Deficiency
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD (NCT07773246) | Korro Bio, Inc. | 2026-09-01 |
| Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency (NCT03636438) | Ultragenyx Pharmaceutical Inc | 2018-08-30 |
| Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset Ornithine Transcarbamylase (OTC) Deficiency (NCT02991144) | Ultragenyx Pharmaceutical Inc | 2017-07-31 |
Track Ornithine Transcarbamylase (OTC) Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.